Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin is a Novel Risk Factor for Cardiometabolic Disorders
Published in "Diabetes 71, 538–553 (2022)"
K.R.A. Prasanna, M.Kiranmayi, S.D.Mukherjee,V.R. Chirasani, R.Garg, D.Vishnuprabu, S.Ravi, L.Subramanian, B.S.Sahu, D. R.Iyer, S.Maghajothi, S.Sharma, M. S.Ravi, M.Khullar, A. K.Munirajan, J.R.Gayen, S.Senapati, A.S.Mullasari, V.Mohan, V.Radha, S.V.Naga Prasad, N.R.Mahapatra